Results 231 to 239 of about 48,863 (239)

Evaluation of efficacy and safety of oral terbinafine and itraconazole combination therapy in the management of dermatophytosis

Journal of dermatological treatment (Print), 2019
Background: There has been an alarming increase in recalcitrant dermatophytosis in recent years. The standard treatment guidelines no longer seem effective in achieving clearance and results in high failure rates.
Priyanka Sharma, M. Bhalla, G. Thami, J. Chander   +3 more
semanticscholar   +1 more source

Clinical experience with new formulation SUBA®-itraconazole for prophylaxis in patients undergoing stem cell transplantation or treatment for haematological malignancies.

Journal of Antimicrobial Chemotherapy, 2019
BACKGROUND SUper BioAvailability-itraconazole (SUBA®-itraconazole) was introduced into Australia in April 2014 as a substitute for standard itraconazole on the basis of improved bioavailability, tolerance and interpatient variability.
B. Nield, S. Larsen, S. V. van Hal
semanticscholar   +1 more source

Comparison of Compounded, Generic, and Innovator-Formulated Itraconazole in Dogs and Cats.

The Journal of the American Animal Hospital Association, 2018
The triazole antifungal itraconazole may be cost prohibitive in brand name form; therefore, compounded and generic products are often used as alternatives.
J. Renschler, Amanda Albers, Hanna Sinclair-Mackling, L. Wheat   +3 more
semanticscholar   +1 more source

“Hedgehog pathway”: a potential target of itraconazole in the treatment of cancer

Journal of Cancer Research and Clinical Oncology, 2020
Xin Wei, Wu Liu, Jia Qi Wang, Zeyao Tang
semanticscholar   +1 more source

Synergistic Effect of Polyvinyl Alcohol and Copovidone in Itraconazole Amorphous Solid Dispersions

Pharmaceutical Research, 2018
K. Wlodarski, Feng Zhang, Tongzhou Liu, W. Sawicki, Thomas Kipping   +4 more
semanticscholar   +1 more source

Enhanced corneal permeation and antimycotic activity of itraconazole against Candida albicans via a novel nanosystem vesicle

Drug Delivery, 2016
A. ElMeshad, A. Mohsen
semanticscholar   +1 more source

Best practices for the use of itraconazole as a replacement for ketoconazole in drug–drug interaction studies

Journal of clinical pharmacology, 2016
Lichuan Liu, A. Bello, M. Dresser, D. Heald, S. Komjathy, E. O'Mara, M. Rogge, S. Stoch, S. M. Robertson   +8 more
semanticscholar   +1 more source

Population In Vitro-In Vivo Correlation Model Linking Gastrointestinal Transit Time, pH, and Pharmacokinetics: Itraconazole as a Model Drug

Pharmaceutical Research, 2016
A. Abuhelwa, Stuart Mudge, David Hayes, R. Upton, D. Foster   +4 more
semanticscholar   +1 more source

Development of a Physiologically Based Pharmacokinetic Model for Itraconazole Pharmacokinetics and Drug–Drug Interaction Prediction

Clinical Pharmacokinetics, 2016
Yuan Chen, Fang Ma, T. Lu, N. Budha, J. Jin, J. Kenny, H. Wong, C. Hop, J. Mao   +8 more
semanticscholar   +1 more source